chr13-108712702-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001198950.3(MYO16):c.334G>A(p.Val112Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000177 in 1,613,964 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001198950.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO16 | ENST00000457511.7 | c.334G>A | p.Val112Ile | missense_variant | 3/35 | 1 | NM_001198950.3 | ENSP00000401633.3 | ||
MYO16 | ENST00000356711.7 | c.268G>A | p.Val90Ile | missense_variant | 3/35 | 1 | ENSP00000349145.2 | |||
MYO16 | ENST00000251041.10 | c.268G>A | p.Val90Ile | missense_variant | 3/25 | 5 | ENSP00000251041.5 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152150Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251060Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135686
GnomAD4 exome AF: 0.000180 AC: 263AN: 1461696Hom.: 0 Cov.: 30 AF XY: 0.000164 AC XY: 119AN XY: 727160
GnomAD4 genome AF: 0.000144 AC: 22AN: 152268Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2022 | The c.334G>A (p.V112I) alteration is located in exon 3 (coding exon 3) of the MYO16 gene. This alteration results from a G to A substitution at nucleotide position 334, causing the valine (V) at amino acid position 112 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at